Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
NCT00237328
·
clinicaltrials.gov ↗
COMPLETED
Status
1015
Enrollment
OTHER
Sponsor class
Conditions
Thrombosis
Interventions
DRUG:
Heparin
Sponsor
Duke University